Sequence Information

    • DRAMP ID

    • DRAMP18157

    • Name

    • NVXT (Novexatin, NP213)

    • Sequence

    • RRRRRRR

    • Description

    • cyclic cationic peptide derived from NovaBiotics arginine peptide platform

    • Activity

    • Antifugal(membrane)

    • Target Organism

      • No MICs found on DRAMP database

    • Reference

      • NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.(PMID: 32232410)

Clinical Information

    • Medical use

    • Onychomycosis (fungal nail infection)

    • Company

    • NovaBiotics

    • Stage of Development

    • Phase IIb

    • Comments

    • No more comments

    • Clinical Trials

    • NCT02933879
    • NCT02343627